Patents by Inventor Sarel Jacob Fleishman

Sarel Jacob Fleishman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240043820
    Abstract: Provided herein are Cas9 proteins comprising SEQ ID NO:1 or a sequence at least 80% identical thereto, wherein: the amino acid residues at positions 765 to 780 are replaced by the amino acid sequence of SEQ ID NO:5 or SEQ ID NO:6; the amino acid residues at positions 838 to 853 are replaced by the amino acid sequence of SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9 or SEQ ID NO:10; and/or the amino acid residues at positions 911 to 925 are replaced by the amino acid sequence of SEQ ID NO:11, SEQ ID NO:12 or SEQ ID NO:13.
    Type: Application
    Filed: December 13, 2021
    Publication date: February 8, 2024
    Inventors: Oliver Rackham, Aleksandra Filipovska, Pascal Vos, Sarel-Jacob Fleishman, Olga Khersonsky
  • Patent number: 9493547
    Abstract: The present invention provides polypeptides that bind to immunoglobulin G and methods for their use.
    Type: Grant
    Filed: March 25, 2013
    Date of Patent: November 15, 2016
    Assignee: University of Washington Through its Center for Commercialization
    Inventors: David Baker, Eva-Maria Strauch, Sarel Jacob Fleishman
  • Publication number: 20150037312
    Abstract: The present invention provides polypeptides that bind to immunoglobulin G and methods for their use.
    Type: Application
    Filed: March 25, 2013
    Publication date: February 5, 2015
    Inventors: David Baker, Sarel Jacob Fleishman, Eva-MarĂ­a Strauch